In the present study, we found that IGU-treated PF mice had reduced TGF-β secretion increased expression of E-cadherin, down-regulated expression of mesenchymal markers vimentin and α-SMA, and less collagen I deposition. The gene discussed is TGFB1; the disease is pemphigus foliaceus.